R. Likar, M. Wittels, M. Molnar, I. Kager, G. Ziervogel et al., Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: A prospective, age-groupcontrolled study, Clin Ther. déc, vol.28, issue.12, pp.2022-2061, 2006.

M. S. Cepeda, F. Camargo, C. Zea, and L. Valencia, Tramadol for osteoarthritis, Cochrane Collab, p.33, 2009.

M. Fitzcharles, D. Lussier, and Y. Shir, Management of Chronic Arthritis Pain in the Elderly, Drugs Aging. juin, vol.27, issue.6, pp.471-90, 2010.

J. M. Hootman and C. G. Helmick, Projections of US prevalence of arthritis and associated activity limitations, Arthritis Rheum. janv, vol.54, issue.1, pp.226-235, 2006.

R. L. Barkin, S. J. Barkin, and D. S. Barkin, Pharmacotherapeutic Management of Pain with a Focus Directed at the Geriatric Patient. Rheum Dis Clin N Am, févr, vol.33, issue.1, pp.1-31, 2007.

F. Boureau and J. F. Doubrère, Du symptôme au syndrome, Douleur Analgésie. mars, vol.1, issue.1, pp.11-18, 1988.

A. Trescot, S. E. Glaser, H. Hansen, R. Benyamin, S. Patel et al., Effectiveness of Opioids in the Treatment of Chronic Non-Cancer Pain, Pain Physician, issue.11, 2008.

O. Engberink, A. Lognos, B. Badin, M. Carbonnel, F. Lalau et al., Prise en charge de la douleur des personnes âgées en soins primaires : l'ouverture vers les interventions non médicamenteuses. Analyse qualitative de l'expérience des médecins généralistes, Presse Médicale. déc, vol.45, issue.12, pp.377-87, 2016.

B. Ph, E. Corruble, G. Derumeaux, B. Falissard, O. Hanon et al., The therapeutic management of chronic pain in ambulatory care patients aged 65 and over in France: the S.AGES cohort. Baseline data, J Nutr Health Aging, vol.17, issue.8, pp.681-687, 2013.

. Ansm, Etat des lieux de la consommation des antalgiques opioïdes et leurs usages problematiques, févr, 2019.

D. Abadie, G. Durrieu, A. Roussin, and J. Montastruc, Effets indésirables « graves » du tramadol : bilan 2010-2011 de pharmacovigilance en France, Thérapie. mars, vol.68, issue.2, pp.77-84, 2013.

, sept, issue.11, 2009.

A. Brocard, S. D. Silva, M. Giroud, A. Putot, and P. Manckoundia, Survey of the prescription of step-2 analgesics in persons aged 75 years and older in general practitioners, Gériatrie Psychol Neuropsychiatr Viellissement. déc, issue.4, pp.383-393, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01670497

P. Dayer, J. Desmeules, and L. Collart, Pharmacologie du tramadol. Drugs, vol.53, issue.2, pp.18-24, 1997.

T. Bamigbade and R. Langford, The clinical use of tramadol hydrochloride, Pain Rev. oct, vol.5, issue.3, pp.155-82, 1998.

D. Lussier and P. Beaulieu, Toward a rational taxonomy of analgesic treatments, Pharmacol Pain IASP Press, pp.27-40, 2010.

R. M. Duehmke, S. Derry, P. J. Wiffen, R. F. Bell, D. Aldington et al., Cochrane Neuromuscular Group, éditeur. Cochrane Database Syst Rev, 2017.

D. Sur,

K. Auret and S. A. Schug, Underutilisation of Opioids in Elderly Patients with Chronic Pain: Approaches to Correcting the Problem, Drugs Aging, vol.22, issue.8, pp.641-54, 2005.

H. Gan, S. Ismail, R. Adnan, W. Zulmi, and W. , Impact of CYP2D6 Genetic Polymorphism on

, Tramadol Pharmacokinetics and Pharmacodynamics. Mol Diagn Ther. mai, vol.11, issue.3, pp.171-81, 2007.

C. Dagostino, M. Allegri, V. Napolioni, D. 'agnelli, S. Bignami et al., CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort, Pharmacogenomics Pers Med. oct, vol.11, pp.179-91, 2018.

P. H. Vuilleumier, U. M. Stamer, and R. Landau, Pharmacogenomic considerations in opioid analgesia, Pharmacogenomics Pers Med. août, pp.73-87, 2012.

L. Jörn, G. Geisslinger, and I. Tegeder, Genetic modulation of the pharmacological treatment of pain, Pharmacol Ther, vol.124, pp.168-84, 2009.

F. Capriz, S. Chapiro, L. David, M. Floccia, C. Guillaumé et al., Consensus multidisciplinaire d'experts en douleur et gériatrie : utilisation des antalgiques dans la prise en charge de la douleur de la personne âgée (hors anesthésie). Douleurs Éval -Diagn -Trait, vol.18, pp.234-281, 2017.

D. Frank, U. Jaehde, and U. Fuhr, Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping, Eur J Clin Pharmacol. 8 mars, vol.63, issue.4, pp.321-354, 2007.

G. Orliaguet, J. Hamza, V. Couloigner, F. Denoyelle, M. Loriot et al., A Case of Respiratory Depression in a Child With Ultrarapid CYP2D6 Metabolism After Tramadol, PEDIATRICS. mars, vol.135, issue.3, pp.753-758, 2015.

J. Desmeules, J. Biollaz, and P. Bonnabry, Interactions médicamenteuses et cytochromes P450, Pharma-Flash, vol.29, issue.4, pp.13-19, 2002.

J. Desmeules, J. Biollaz, and P. Bonnabry, Importance des cytochromes P450: pharmacogénétique et intéractions médicamenteuses, Pharma-Flash, vol.37, issue.2, 2010.

D. Lewis, P. J. Eddershaw, P. S. Goldfarb, and M. H. Tarbit, Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102 : structural studies on specific CYP2D6 substrate metabolism, Xenobiotica. janv, vol.27, issue.4, pp.319-359, 1997.

. Ansm, Interactions médicamenteuses et cytochromes, 2017.

A. Axmon, M. Sandberg, G. Ahlström, and P. Midlöv, Prescription of potentially inappropriate medications among older people with intellectual disability: a register study, Disponible sur, vol.18, 2017.

C. K. O'neil, J. T. Hanlon, and Z. A. Marcum, Adverse Effects of Analgesics Commonly Used by Older Adults With Osteoarthritis: Focus on Non-Opioid and Opioid Analgesics, Am J Geriatr Pharmacother. déc, vol.10, issue.6, pp.331-373, 2012.

K. Belfihadj, Prise en soins de la douleur en EHPAD, NPG Neurol -Psychiatr -Gériatrie. août, vol.18, issue.106, pp.218-243, 2018.

A. A. Mangoni and S. Jackson, Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications: Age-related changes in pharmacokinetics and pharmacodynamics, Br J Clin Pharmacol, vol.57, issue.1, pp.6-14, 2003.

R. E. Hubbard, M. S. O'mahony, and K. W. Woodhouse, Medication prescribing in frail older people, Eur J Clin Pharmacol. mars, vol.69, issue.3, pp.319-345, 2013.

M. Rainfray, S. Richard-harston, N. Salles-montaudon, and J. P. Emeriau, Les effets du vieillissement sur la fonction rénale et leurs implications en pratique médicale, Presse Médicale. juill, vol.29, issue.24, pp.1373-1381, 2000.

M. Salive, C. Jones, J. Guralnik, L. Agodoa, M. Pahor et al., Serum creatinine levels in older adults: relationship with health status and medications, Age Ageing. mars, vol.24, issue.2, pp.142-50, 1995.

S. Skinner-robertson, C. Fradette, S. Bouchard, M. Mouksassi, and F. Varin, Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects, Drugs Aging. déc, vol.32, issue.12, pp.1029-1072, 2015.

S. Legrain, H. Autorité-de, and . Santé, Consommation Médicamenteuse chez le Sujet Agé, 2005.

A. R. Huang and L. Mallet, Prescribing opioids in older people, Maturitas. févr, vol.74, issue.2, pp.123-132, 2013.

J. B. Garner, Problems of Nonadherence in Cardiology and Proposals to Improve Outcomes, Am J Cardiol. mai, vol.105, issue.10, pp.1495-501, 2010.

S. Thevelin, L. El-mounaouar, S. Marien, B. Boland, S. Henrard et al., Potentially Inappropriate Prescribing and Related Hospital Admissions in Geriatric Patients: A Comparative Analysis between the STOPP and START Criteria Versions 1 and 2, J Am Geriatr Soc. sept, vol.36, issue.5, pp.2052-2058, 2017.

, American Geriatrics Society. American Geriatrics Society, 2019.

, Potentially Inappropriate Medication Use in Older Adults: 2019 AGS Beers Criteria® Update expert panel, J Am Geriatr Soc, vol.67, issue.4, pp.674-94, 2019.

D. O'mahony, O. 'sullivan, D. Byrne, S. O'connor, M. N. Ryan et al., STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing, vol.44, pp.213-221, 2014.

L. Morin, M. Laroche, G. Texier, and K. Johnell, Prevalence of Potentially Inappropriate Medication Use in Older Adults Living in Nursing Homes: A Systematic Review, J Am Med Dir Assoc. sept, vol.17, issue.9, pp.862-863, 2016.

M. Laroche, J. Charmes, and M. L. , Potentially inappropriate medications in the elderly: a French consensus panel list, Eur J Clin Pharmacol. juill, vol.63, issue.8, pp.725-756, 2007.

S. Rognstad, M. Brekke, A. Fetveit, O. Spigset, T. B. Wyller et al., The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients: A modified Delphi study. Scand J Prim Health Care, janv, vol.27, issue.3, pp.153-162, 2009.

C. Thorne, A. D. Beaulieu, D. J. Callaghan, W. F. O'mahony, J. M. Bartlett et al., Double-Blind, Crossover Comparison of the Efficacy and Safety of Oral Controlled-Release Tramadol and Placebo in Patients with Painful Osteoarthritis, Pain Res Manag, vol.13, issue.2, pp.93-102, 2008.

L. Morin, J. Fastbom, M. Laroche, and K. Johnell, Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population-based estimates: Comparing different explicit criteria of potentially inappropriate drug use, Br J Clin Pharmacol. août, vol.80, issue.2, pp.315-339, 2015.

G. Bouvenot and P. Villani, Apport des essais pré-AMM à la connaissance du risque iatrogène chez la personne âgée, Thérapie. mars, vol.59, issue.2, pp.233-239, 2004.

, American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological Management of Persistent Pain in Older Persons, J Am Geriatr Soc. août, vol.57, issue.8, pp.1331-1377, 2009.

S. Skinner-robertson and M. Mouksassi, Population Pharmacokinetic/Pharmacodynamic Modeling of O-Desmethyltramadol in Young and Elderly Healthy Volunteers, Drugs Aging, pp.1-12, 2019.

R. Prescrire, Tramadol buvable avec compte-gouttes: pourquoi un carton jaune? Prescrire, vol.37, p.390, 2017.

A. , Réunion du Comité technique de Pharmacovigilance, 2016.

B. Delemos, H. M. Richards, J. Vandenbossche, J. Ariyawansa, J. Natarajan et al.,

T. Safety, Pharmacokinetics of Therapeutic and Supratherapeutic Doses of Tramadol Hydrochloride in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Multiple-Ascending-Dose Study, Clin Pharmacol Drug Dev, vol.00, issue.0, pp.592-603, 2017.

M. Crossman, C. Kohnen, R. Langford, and C. Mccartney, Tolérance et sécurité d'emploi du tramadol -Résultats des études internationales et données de la pharmacovigilance, Drugs, vol.53, issue.2, pp.50-62, 1997.

F. Aubrun and F. Marmion, The elderly patient and postoperative pain treatment, Best Pract Res Clin Anaesthesiol. mars, vol.21, issue.1, pp.109-136, 2007.

D. Petrone, M. Kamin, and W. Olson, Slowing the titration rate of tramadol HCl reduces the incidence of discontinuation due to nausea and/or vomiting: a double-blind randomized trial, J Clin Pharm Ther. avr, vol.24, issue.2, pp.115-138, 1999.

I. Tagarro, J. Herrera, C. Barutell, M. C. Diez, M. Marin et al., Effect of a Simple Dose-Escalation Schedule on Tramadol Tolerability: Assessment in the Clinical Setting, Clin Drug Investig, vol.25, issue.1, pp.23-31, 2005.

G. Ruoff, Slowing the Initial Titration Rate of Tramadol Improves Tolerability, Pharmacotherapy. janv, vol.19, issue.1, pp.88-93, 1999.

J. G. Naples, W. F. Gellad, and J. T. Hanlon, The Role of Opioid Analgesics in Geriatric Pain Management, Clin Geriatr Med. nov, vol.32, issue.4, pp.725-760, 2016.

B. Lesourd, F. Ziegler, and C. Aussel, La nutrition des personnes âgées : place et pièges du bilan biologique, Ann Biol Clin (Paris). août, vol.59, issue.4, pp.445-52, 2001.

, Stratégie de prise en charge en cas de dénutrition protéino-énergétique chez la personne âgée, Serv Recomm Prof. avr, 2007.

, Évaluation diagnostique de la dénutrition protéino-énergétique des adultes hospitalisés, Serv Recomm Prof. sept, 2003.

F. Serrano, E. Vidal-petiot, and M. Flamant, Evaluer la fonction rénale, Rev Prat Médecine Générale. sept, vol.29, issue.945, pp.2-4, 2015.

L. Cossec, C. Sermet, C. Perronnin, and M. , Mesurer la polymédication chez les personnes âgées : impact de la méthode sur la prévalence et les classes thérapeutiques. Quest D'économie Santé, 8. 67. ANSM. Thesaurus des intéractions médicamenteuses, 2015.

C. L. Drees and N. Pradines, État de santé et dépendance des personnes âgées en institution ou à domicile, Etudes Résultats. déc, issue.0988, 2016.

M. Drees, 728 000 résidents en établissements d'hébergement pour personnes âgées en 2015. Premiers résultats de l'enquête EHPA 2015, Etudes Résultats. juill, 1015.

J. Dartigues, C. Helmer, and L. Letenneur, Épidémiologie des démences, Gérontologie Société. févr, vol.24, issue.97, pp.75-90, 2001.

C. P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni et al., Global prevalence of dementia: a Delphi consensus study, The Lancet. déc, vol.366, issue.9503, pp.2112-2119, 2005.

U. Lucca, M. Tettamanti, G. Logroscino, P. Tiraboschi, C. Landie et al., Prevalence of dementia in the oldest old: The Monzino 80-plus population based study, Alzheimers Dement. mars, vol.11, issue.3, pp.258-70, 2015.

R. A. Payne, A. J. Avery, M. Duerden, C. L. Saunders, C. R. Simpson et al., Prevalence of polypharmacy in a Scottish primary care population, Eur J Clin Pharmacol. mai, vol.70, issue.5, pp.575-81, 2014.

R. S. Wilson, L. E. Hebert, P. A. Scherr, X. Dong, S. E. Leurgens et al., Cognitive decline after hospitalization in a community population of older persons, Neurology. mars, vol.78, pp.950-956, 2012.

K. A. Wallis, A. Andrews, and M. Henderson, Swimming Against the Tide: Primary Care Physicians' Views on Deprescribing in Everyday Practice, Ann Fam Med. juill, vol.15, issue.4, pp.341-347, 2017.

J. Fournier, H. Yin, S. J. Nessim, J. Montastruc, and L. Azoulay, Tramadol for Noncancer Pain and the Risk of Hyponatremia, Am J Med. avr, vol.128, issue.4, pp.418-443, 2015.

J. Fournier, L. Azoulay, H. Yin, J. Montastruc, and S. Suissa, Tramadol Use and the Risk of Hospitalization for Hypoglycemia in Patients With Noncancer Pain, JAMA Intern Med. févr, vol.175, issue.2, pp.186-93, 2015.

A. Pottegård, P. M. Meegaard, L. Holck, . Christensen-r-depont, H. Madsen et al., Concurrent use of tramadol and oral vitamin K antagonists and the risk of excessive anticoagulation: a registerbased nested case-control study, Eur J Clin Pharmacol. mars, vol.69, issue.3, pp.641-647, 2013.

, « Par délibération de son Conseil en date du 10 Novembre 1972